top of page
Phone: 888-855-0947 Office Hours: M-F 10am-6pm Fax: 346-766-0599
After hours: If urgent, life threatening (please call 988, 911, or go to nearest ER. Otherwise, for side effects to medications, please text 816-766-0119. For all other non-urgent issues, please contact us Practice Q messaging portal or contact us during clinic hours at 888-855-0947.
two women talking and smiling
a boy bow down on floor
a women crying while holding a hand
two women talking and smiling
1/3
Ready for your Mental Health Transformation?
Child Psychiatrist /Adult Psychiatrist
Blog
Search
Why Depression Hits Girls Harder Than Boys
Girls are twice as likely as boys to be diagnosed with depression, and researchers in London have now uncovered clues as to why. Girls'...
Vilash Reddy, MD
14 minutes ago3 min read
0
0
When Treating Obesity, Don’t Forget the Mental Health Angle
When the 42-year-old patient came to see Yarickza Lopez, MSN, FNP-C, the 5-ft woman weighed 260 lb and had severe depression and anxiety,...
Vilash Reddy, MD
Feb 287 min read
0
0
Virtual Reality Meditation for Major Depressive Disorder
Key Takeaways Immersive VR meditation offers personalized experiences, enhancing symptom relief for MDD and GAD compared to traditional...
Vilash Reddy, MD
Feb 33 min read
5
0
Major Depression in Older Adults Tied to Risky Driving Behaviors
Older adults with major depressive disorder (MDD) exhibit riskier driving behaviors than their nondepressed peers, including hard...
Vilash Reddy, MD
Jan 83 min read
2
0
Higher-Speed Traffic Noise May Up Stress, Anxiety
TOPLINE: Listening to recordings of natural soundscapes may help reduce anxiety and stress, but adding in high-traffic noise can mask the...
Vilash Reddy, MD
Jan 32 min read
0
0
Two Brain Stim Methods Better Than One for Depression?
TOPLINE: Combining transcranial direct current stimulation (tDCS) and repetitive transcranial magnetic stimulation (rTMS) was associated...
Vilash Reddy, MD
Nov 21, 20242 min read
2
0
Newly FDA-Cleared TMS for Major Depressive Disorder
Key Takeaways Magstim's Horizon Inspire TMS system is FDA-cleared for MDD, OCD, and anxious depression, offering a nonpharmacological...
Vilash Reddy, MD
Nov 13, 20243 min read
1
0
New Hope for Rapid-Acting Depression Treatment
Depression symptoms can be hard to manage, especially for people with treatment-resistant depression, a persistent and severe form of the...
Vilash Reddy, MD
Oct 27, 20244 min read
4
0
New Treatment Effective for Male Postpartum Depression
A psychosocial intervention designed to improve depressive symptoms and promote good parenting skills can be an effective way of treating...
Vilash Reddy, MD
Oct 14, 20244 min read
0
0
Genetically Driven Depression Tied to Increased MS Disease Activity
COPENHAGEN, Denmark — A higher cumulative genetic burden for depression is associated with an increased risk for relapse and worsening...
Vilash Reddy, MD
Sep 26, 20244 min read
1
0
Slow-Release Oral Ketamine Formulations Show Promise for At-Home Treatment of Resistant Depression
Key Point: Phase 2 trials suggest extended-release oral ketamine formulations could be alternative to clinic-administered treatment for...
Vilash Reddy, MD
Sep 6, 20244 min read
2
0
Smartphone Data May Not Reliably Predict Depression Risk in Diverse Groups
Smartwatches, smartphones, and other wearable devices are transforming how we track our physical health and behavior. Researchers are...
Vilash Reddy, MD
Aug 27, 20243 min read
1
0
Could Methylene Blue Help Treat Depression?
Keypoint: Why a blue dye may be a viable treatment for psychiatric disorders. Methylene blue is both a dye and a medicine. Methylene blue...
Vilash Reddy, MD
Aug 4, 20244 min read
11
0
Zuranolone for the Treatment of Adults With Major Depressive Disorder
Keypoint: This randomized, placebo-controlled, phase 3 clinical trial showed that a 14-day treatment course of oral zuranolone 50 mg/day...
Vilash Reddy, MD
Jul 18, 20245 min read
0
0
Oral Extended-Release Ketamine Promising for Treatment-Resistant Depression
An extended-release oral tablet formulation of ketamine has shown promise for treatment-resistant depression (TRD) results of a phase 2...
Vilash Reddy, MD
Jun 25, 20243 min read
1
0
Early-Life Exposure to Pollution Linked to Psychosis, Anxiety, Depression
Early-life exposure to air and noise pollution is associated with a higher risk for psychosis, depression, and anxiety in adolescence and...
Vilash Reddy, MD
Jun 14, 20243 min read
0
0
Teen Cannabis Use Tied to Dramatic Increased Risk for Psychosis
Teenagers who use cannabis have a dramatic increased risk for a psychotic disorder compared with their counterparts who don't use the...
Vilash Reddy, MD
Jun 5, 20243 min read
3
0
What Is the Optimal Dose of Ketamine for Treatment Resistant Depression?
Keypoint: Higher IV ketamine doses do not outperform standard doses for treatment resistant depression. Intravenous (IV) ketamine for...
Vilash Reddy, MD
May 6, 20242 min read
3
0
Antidepressants Differ by Long-Term Response in Major Depression
Antidepressants differ in improving symptoms and preventing relapse of major depressive disorder (MDD) over a 2-year period, according to...
Vilash Reddy, MD
May 1, 20244 min read
1
0
Managing Suicidal Thoughts, Behaviors, and Risk in Treatment-Resistant Depression
Suicidal thoughts and behaviors (STBs) are among the most dreaded complications of treatment-resistant depression (TRD), which is...
Vilash Reddy, MD
Apr 17, 20247 min read
1
0
bottom of page